Lonza | LONN - Nettoeinkommen

Aktienkurs
474.00
Täglich Wechseln
-8.70 -1.80%
Monatlich
-4.90%
Jährlich
-19.47%
Q2 Prognose
470.40




Nettoeinkommen Veränderung Datum
Akzo Nobel EUR 93M 505M 2026-03
Alcon AG USD 217M 20M 2025-12
Almirall EUR 19.58M 7M 2025-12
AstraZeneca USD 3.08B 754M 2026-03
BASF EUR 560M 388M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Beiersdorf EUR 387M 165M 2025-12
Covestro EUR -378M 331M 2025-12
Demant DKK 427M 690M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 327M 52.2M 2025-12
Geberit CHF 103.5M 52.3M 2025-12
Genmab DKK 31M 370M 2025-12
Givaudan CHF 479M 113M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GN Store Nord DKK 344M 271M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Johnson Matthey GBP -18M 93M 2025-12
Merck EUR 319M 583M 2025-12
Novartis USD 3.16B 747M 2026-03
Philips EUR 395M 211M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Sika AG CHF 490.2M 63.6M 2025-12
Smith & Nephew USD 293M 79M 2025-12
Solvay EUR -95M 129M 2025-12
UCB EUR 1.08B 608M 2025-12